Journal of the American Society of Nephrology
2008 JASN IMPACT FACTOR 7.505 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on March 30, 2005
Journal of the American Society of Nephrology
© 2005 American Society of Nephrology
doi: 10.1681/ASN.2005010078
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
ASN.2005010078v1
16/5/1392    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Appel, G. B.
Right arrow Articles by Zipfel, P. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Appel, G. B.
Right arrow Articles by Zipfel, P. F.

DISEASE OF THE MONTH

Membranoproliferative Glomerulonephritis Type II (Dense Deposit Disease): An Update

Gerald B. Appel 1, H. Terence Cook 2, Gregory Hageman 3, J. Charles Jennette 4, Michael Kashgarian 5, Michael Kirschfink 6, John D. Lambris 7, Lynne Lanning 8, Hans U. Lutz 9, Seppo Meri 10, Noel R. Rose 11, David J. Salant 12, Sanjeev Sethi 13, Richard J.H. Smith 14*, William Smoyer 15, Hope F. Tully 16, Sean P. Tully 16, Patrick Walker 17, Michael Welsh 18, Reinhard Würzner 19, Peter F. Zipfel 20

1

*Columbia University Department of Nephrology, New York, New York


2

{dagger}Division of Investigative Science, Imperial College Faculty of Medicine, London, England


3

{ddagger}Department of Ophthalmology and Visual Sciences, University of Iowa, Carver College of Medicine, Iowa City, Iowa


4

{sect}Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, North Carolina


5

||Department of Pathology, Yale University School of Medicine, New Haven, Connecticut


6

Institute of Immunology, University of Heidelberg, Heidelberg, Germany


7

#Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania


8

**Kidneeds, Iowa City, Iowa


9

{dagger}{dagger}Institute of Biochemistry, Swiss Federal Institute of Technology, Zurich, Switzerland


10

{ddagger}{ddagger}Department of Bacteriology and Immunology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland


11

{sect}{sect}Center for Autoimmune Disease Research, Johns Hopkins School of Medicine, Baltimore, Maryland


12

||||Department of Medicine, Boston University Medical Center, Boston, Massachusetts


13

¶¶Department of Pathology, University of Iowa, Carver College of Medicine, Iowa City, Iowa


14

##Department of Otolaryngology, University of Iowa Carver College of Medicine, Iowa City, Iowa


15

***Pediatric Nephrology Division, University of Michigan, Ann Arbor, Michigan


16

{dagger}{dagger}{dagger}Milagros Research Fund, Chappaqua, New York, New York


17

{ddagger}{ddagger}{ddagger}Nephropathology Associates, Little Rock, Arkansas


18

{sect}{sect}{sect}Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa


19

||||||Department of Hygiene, Microbiology and Social Medicine, Innsbruck Medical University, Innsbruck, Austria


20

¶¶¶Hans Knoell Institute for Natural Products Research, Jena, Germany


* To whom correspondence should be addressed. E-mail: richard-smith{at}uiowa.edu.


  Abstract

Membranoproliferative glomerulonephritis type II (MPGN II) is a rare disease characterized by the deposition of abnormal electron-dense material within the glomerular basement membrane of the kidney and often within Bruch’s membrane in the eye. The diagnosis is made in most patients between the ages of 5 and 15 yr, and within 10 yr, approximately half progress to end-stage renal disease, occasionally with the late comorbidity of visual impairment. The pathophysiologic basis of MPGN II is associated with the uncontrolled systemic activation of the alternative pathway (AP) of the complement cascade. In most patients, loss of complement regulation is caused by C3 nephritic factor, an autoantibody directed against the C3 convertase of the AP, but in some patients, mutations in the factor H gene have been identified. For the latter patients, plasma replacement therapy prevents renal failure, but for the majority of patients, there is no proven effective treatment. The disease recurs in virtually all renal allografts, and a high percentage of these ultimately fail. The development of molecular diagnostic tools and new therapies directed at controlling the AP of the complement cascade either locally in the kidney or at the systemic level may lead to effective treatments for MPGN II.


This article has been cited by other articles:


Home page
 BloodHome page
S. Heinen, A. Hartmann, N. Lauer, U. Wiehl, H.-M. Dahse, S. Schirmer, K. Gropp, T. Enghardt, R. Wallich, S. Halbich, et al.
Factor H-related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation
Blood, September 17, 2009; 114(12): 2439 - 2447.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
Y. B. D'souza and C. D. Short
The eye--a window on the kidney
Nephrol. Dial. Transplant., August 12, 2009; (2009) gfp406v1.
[Full Text] [PDF]

Home page
 CJASNHome page
S. H. Nasr, A. M. Valeri, G. B. Appel, J. Sherwinter, M. B. Stokes, S. M. Said, G. S. Markowitz, and V. D. D'Agati
Dense Deposit Disease: Clinicopathologic Study of 32 Pediatric and Adult Patients
Clin. J. Am. Soc. Nephrol., January 1, 2009; 4(1): 22 - 32.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
X. Wu, D. Spitzer, D. Mao, S. L. Peng, H. Molina, and J. P. Atkinson
Membrane Protein Crry Maintains Homeostasis of the Complement System
J. Immunol., August 15, 2008; 181(4): 2732 - 2740.
[Abstract] [Full Text] [PDF]

Home page
 Br J OphthalmolHome page
Y D'souza, C D Short, D McLeod, and R E Bonshek
Long-term follow-up of drusen-like lesions in patients with type II mesangiocapillary glomerulonephritis
Br J Ophthalmol, July 1, 2008; 92(7): 950 - 953.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
G. Liew, P. Mitchell, T. Y. Wong, S. K. Iyengar, and J. J. Wang
CKD Increases the Risk of Age-Related Macular Degeneration
J. Am. Soc. Nephrol., April 1, 2008; 19(4): 806 - 811.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
G. T. Le, G. Abbenante, and D. P. Fairlie
Profiling the Enzymatic Properties and Inhibition of Human Complement Factor B
J. Biol. Chem., November 30, 2007; 282(48): 34809 - 34816.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
C. L. Thompson, B. E.K. Klein, R. Klein, Z. Xu, J. Capriotti, T. Joshi, D. Leontiev, K. E. Lee, R. C. Elston, and S. K. Iyengar
Complement factor H and hemicentin-1 in age-related macular degeneration and renal phenotypes
Hum. Mol. Genet., September 1, 2007; 16(17): 2135 - 2148.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
R. J.H. Smith, J. Alexander, P. N. Barlow, M. Botto, T. L. Cassavant, H. T. Cook, S. R. de Cordoba, G. S. Hageman, T. S. Jokiranta, W. J. Kimberling, et al.
New Approaches to the Treatment of Dense Deposit Disease
J. Am. Soc. Nephrol., September 1, 2007; 18(9): 2447 - 2456.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
J. R.W. Yates, T. Sepp, B. K. Matharu, J. C. Khan, D. A. Thurlby, H. Shahid, D. G. Clayton, C. Hayward, J. Morgan, A. F. Wright, et al.
Complement C3 Variant and the Risk of Age-Related Macular Degeneration
N. Engl. J. Med., August 9, 2007; 357(6): 553 - 561.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Z. Wu, T. W. Lauer, A. Sick, S. F. Hackett, and P. A. Campochiaro
Oxidative Stress Modulates Complement Factor H Expression in Retinal Pigmented Epithelial Cells by Acetylation of FOXO3
J. Biol. Chem., August 3, 2007; 282(31): 22414 - 22425.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
D. J. Salant, V. Sanchorawala, and V. D. D'Agati
A Case of Atypical Light Chain Deposition Disease--Diagnosis and Treatment
Clin. J. Am. Soc. Nephrol., July 1, 2007; 2(4): 858 - 867.
[Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
J. J. Alexander, Y. Wang, A. Chang, A. Jacob, A. W.M. Minto, M. Karmegam, M. Haas, and R. J. Quigg
Mouse Podocyte Complement Factor H: The Functional Analog to Human Complement Receptor 1
J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1157 - 1166.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
L. Bao, Y. Wang, A. Chang, A. W. Minto, J. Zhou, H. Kang, M. Haas, and R. J. Quigg
Unrestricted C3 Activation Occurs in Crry-Deficient Kidneys and Rapidly Leads to Chronic Renal Failure
J. Am. Soc. Nephrol., March 1, 2007; 18(3): 811 - 822.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
A. Servais, V. Fremeaux-Bacchi, M. Lequintrec, R. Salomon, J. Blouin, B. Knebelmann, J.-P. Grunfeld, P. Lesavre, L.-H. Noel, and F. Fakhouri
Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome
J. Med. Genet., March 1, 2007; 44(3): 193 - 199.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
K O Alsaad and A M Herzenberg
Distinguishing diabetic nephropathy from other causes of glomerulosclerosis: an update
J. Clin. Pathol., January 1, 2007; 60(1): 18 - 26.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
M A Abrera-Abeleda, C Nishimura, J L H Smith, S Sethi, J L McRae, B F Murphy, G Silvestri, C Skerka, M Jozsi, P F Zipfel, et al.
Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease)
J. Med. Genet., July 1, 2006; 43(7): 582 - 589.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. C. Pickering, J. Warren, K. L. Rose, F. Carlucci, Y. Wang, M. J. Walport, H. T. Cook, and M. Botto
Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient mice
PNAS, June 20, 2006; 103(25): 9649 - 9654.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. M. Thurman and V. M. Holers
The Central Role of the Alternative Complement Pathway in Human Disease
J. Immunol., February 1, 2006; 176(3): 1305 - 1310.
[Abstract] [Full Text] [PDF]


HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP

Copyright © 2009 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673